Week 96 Subgroup Analyses of the Phase 3, Randomized AMBER and EMERALD Trials Evaluating the Efficacy and Safety of the Once Daily Darunavir/cobicistat/emtricitabine/tenofovir Alafenamide (D/C/F/TAF) Single-Tablet Regimen in Antiretroviral Treatment (Art)-Naïve and -Experienced, Virologically-Suppressed Adults Living with HIV-1.
HIV Research & Clinical Practice（2020）
Key words
TAF,HIV-1,darunavir,single-tablet regimen,tenofovir alafenamide,subgroup analysis,Phase III
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined